Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000483029 | SCV000574236 | uncertain significance | not provided | 2024-01-11 | criteria provided, single submitter | clinical testing | Reported along with a second variant in the FAT4 gene in a patient with Fanconi anemia in the published literature; however, segregation information and additional clinical information were not provided (PMID: 23623386); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23623386) |
Baylor Genetics | RCV001333192 | SCV001525707 | uncertain significance | Hennekam lymphangiectasia-lymphedema syndrome 2 | 2018-04-18 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV000483029 | SCV001696035 | likely benign | not provided | 2025-01-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003902733 | SCV004720378 | likely benign | FAT4-related disorder | 2022-11-29 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |